Cutler Group LP Unity Biotechnology, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Jan 21, 2021
SELL
$3.42 - $6.36 $11,970 - $22,260
-3,500 Reduced 72.92%
1,300 $0
Q3 2020

Oct 27, 2020
BUY
$2.94 - $12.43 $8,232 - $34,804
2,800 Added 140.0%
4,800 $0
Q2 2020

Jul 22, 2020
BUY
$5.28 - $9.67 $7,920 - $14,505
1,500 Added 300.0%
2,000 $1,000
Q1 2020

May 07, 2020
BUY
$5.0 - $7.6 $1,000 - $1,520
200 Added 66.67%
500 $0
Q4 2019

Feb 06, 2020
BUY
$5.99 - $8.38 $1,797 - $2,514
300 New
300 $0

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $14.5M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email